马来酰亚胺基己酰-L-缬氨酸-L-瓜氨酸对氨基苄醇 对硝基苯基碳酸脂

马来酰亚胺基己酰-L-缬氨酸-L-瓜氨酸对氨基苄醇 对硝基苯基碳酸脂性质、用途与生产工艺

用途

生物活性

靶点

马来酰亚胺基己酰-L-缬氨酸-L-瓜氨酸对氨基苄醇 对硝基苯基碳酸脂 上下游产品信息

上游原料

下游产品

马来酰亚胺基己酰-L-缬氨酸-L-瓜氨酸对氨基苄醇 对硝基苯基碳酸脂 生产厂家

159857-81-5, 马来酰亚胺基己酰-L-缬氨酸-L-瓜氨酸对氨基苄醇 对硝基苯基碳酸脂 相关搜索:

• ADC-Linkers
• ADC-Linker
• ADCs Linkers
• ADCs
• 抑制剂
• 多肽合成
• 黄金产品
• 高端化学
• 目录肽
• 化学试剂
• 生物试剂
• 医用原料
• 原料药
• 多肽
• 医药原料药
• C35H43N7O11
• 159857-81-6
• 鸟氨酸杂质13
• 化合物MC-VAL-CIT-PABC-PNP
• 4-(2S)-5-氨基甲酰氨基-2-(2S)-2-(6-(2,5-二氧代-2,5-二氢-1H-吡咯-1-基)己酰胺)-3-甲基丁酰胺]戊酰胺]苯基)甲基 4-硝基苯基碳酸酯
• 马来酰亚胺基己酰-L-缬氨酸-L-瓜氨酸对氨基苄醇
• 多肽MC-VAL-CIT-PABC-PNP
• 组织蛋白酶可裂解的 ADC 接头多肽
• 马来酰亚胺基己酰-L-缬氨酸
• 马来酰亚胺基己酰-L-缬氨酸-L-瓜氨酸对氨基苄醇 对硝基苯基碳酸脂 6级
• 4-((S)-2-((S)-2-(6-(2,5-二氧代-2,5-二氢-1H-吡咯-1-基)己酰胺)-3-甲基丁酰氨基)-5-脲基戊酰胺基)苄基 (4-硝基苯基)碳酸酯
• MC-VAL-CIT-PAB-PNP 酯
• 马来酰亚胺基己酰-L-缬氨酸-L-瓜氨酸对氨基苄醇 对硝基苯基碳酸脂
• 159857-81-5
• Inhibitor|||inhibit|||MC-Val-Cit-PABC-PNP|||Maleimidocaproyl-L-valine-L-citrulline-p-aminobenzyl alcohol p-nitrophenyl carbonate|||Maleimidocaproyl-L-valine-L-citrulline-p-aminobenzyl alcohol p-nitrophenyl carbonate|||ADC Linkers|||MC Val Cit PABC PNP|||Antibody-drug conjugate
• (4-[(2S)-5-(carbamoylamino)-2-[(2S)-2-(6-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)hexanamido)-3-methylbutanamido]pentanamido]phenyl)methyl 4-nitrophenyl carbonate
• Ornithine Impurity 13
• Top quality 159857-81-5 MC-Val-Cit-PABC
• N-[6-(2,5-Dihydro-2,5-dioxo-1H-pyrrol-1-yl)-1-oxohexyl]-L-valyl-N5-(aminocarbonyl)-N-[4-[[[(4-nitrophenoxy)carbonyl]oxy]methyl]phenyl]-L-ornithinamide
• 1H-Indene-1,3(2H)-dione,5,8-dichloro-
• MC-Val-Cit-PAB-PNP
• MC-VAL-CIT-PAB-PNB
• MC-VC-PAB-PNP
• Mc-Val-Cit-PABC-PNP
• MC-Val-Cit-PABC
• L-Ornithinamide
• Mc-Val-Cit-PABC-PNP (Maleimidocaproyl-L-valine-L-citrulline-p-aminobenzyl alcohol p-nitrophenyl carbonate)
• CS-1787
• Mc-Val-Cit-PABC-PNP(VCMMAE linker)
• [4-[[(2S)-2-[[(2S)-2-[6-(2,5-dioxopyrrol-1-yl)hexanoylamino]-3-methyl-butanoyl]amino]-5-ureido-pentanoyl]amino]phenyl]methyl (4-nitrophenyl) carbonate
• N-[6-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)hexanoyl]-L-valyl-N5-carbamoyl-N[4-({[(4-nitrophenoxy)carbonyl]oxy}methyl)phenyl]-L-ornithinamide
• VCMMAE linker
• JACS-159857-81-5
• N-[6-(2,5-dihydro-2,5-dioxo-1H-pyrrol-1-yl)-1-oxohexyl]-L-valyl-N5-(aMinocarbonyl)-N-[4-[[[(4-nitrophenoxy)carbonyl]oxy]Methyl]phenyl]-
• L-OrnithinaMide, N-[6-(2,5-dihydro-2,5-dioxo-1H-pyrrol-1-yl)-1-oxohexyl]-L-valyl-N5-(aMinocarbonyl)-N-[4-[[[(5-nitrophenoxy)carbonyl]oxy]Methyl]phenyl]-
• 4-((S)-2-((S)-2-(6-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)hexanamido)-3-methylbutanamido)-5-ureidopentanamido)benzyl 4-nitrophenyl carbonate,linker
• N-(6-Maleimidocaproyl)-L-valyl-N5-carbamoyl-N-[4-[[[(4-nitrophenoxy)carbonyl]oxy]methyl]phenyl
• L-OrnithinaMide, N-[6-(2,5-dihydro-2,5-dioxo-1H-pyrrol-1-yl)-1-oxohexyl]-L-valyl-N5-(aMinocarbonyl)-N-[4-[[[(4-nitrophenoxy)carbonyl]oxy]Methyl]phenyl]- ISO 9001：2015 REACH
• SKL361
• AK-32171
• [4-[[(2S)-5-(carbamoylamino)-2-[[(2S)-2-[6-(2,5-dioxopyrrol-1-yl)hexanoylamino]-3-methylbutanoyl]amino]pentanoyl]amino]phenyl]methyl (4-nitrophenyl) carbonate
• MC-VAL-CIT-PABC-PNP;MC-VC-PAB-PNP;MC-VAL-CIT-PAB-PNB;MC-VAL-CIT-PAB-PNP
• MC-VC-PAB-PNP,Mc-Val-Cit-PABC-PNP